<DOC>
	<DOCNO>NCT02777879</DOCNO>
	<brief_summary>This cross sectional case control study ass lung microbiome inflammation smoker without Chronic Obstructive Pulmonary Disease ( COPD ) . Investigators look active bacterial metabolic pathway low airway use metagenomic metabolomic approach assess relationship among microbiome , metagenome , metabolome host immune response COPD control . Investigators believe COPD case high prevalence pneumotype supraglottic predominant taxon ( SPT ) match control .</brief_summary>
	<brief_title>Lung Microbiome Inflammation Early COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Case definition : Smokers ( &gt; 20 packyear ) airflow obstruction ( FEV1/FVC &lt; 70 ) FEV1 &gt; 50 % predict ( early COPD GOLD 1 2 ) Control definition : Smokers normal spirometry serve control . FEV1 &lt; 70 % . Significant cardiovascular disease define abnormal EKG , know suspect coronary artery disease congestive heart failure . Diabetes mellitus Significant liver renal disease Severe coagulopathy ( INR &gt; 1.4 , PTT &gt; 40 second platelet count &lt; 150x103 cell ) . Pregnancy ETOH use &gt; 6 beer &gt; 4 mixed drink daily Lack capacity provide inform consent . Antibiotic inhale steroid use within prior six month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease ( COPD )</keyword>
</DOC>